Atreo, a San Francisco, CA-based Clinical Development SaaS company focused on modernizing and simplifying the clinical trials process, raised $4M in funding.
Lead Investors include RTSM & clinical supplies founders and life sciences executives, as well as Slack Co-Founders Stewart Butterfield and Cal Henderson.
The company, which has raised $5.75m in total funding, intends to use the funds to accelerate growth and expand operations.
Led by CEO Ryan Harrison and COO Jon Ball, Atreo is a clinical technology company that provides a randomization and trial supply management (RTSM) platform to modernize the RTSM experience with agility and simplicity by leveraging advanced technology and testing methods. Atreo has addressed all common RTSM pain points.
FinSMEs
10/08/2022